Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features
Spending largely rebounds within a year, according to Petch, but with a preference shift leaning into produce, tea, nuts and foods high in fibre and protein
If the break has been longer than two weeks, restarting at a lower dose is often advised to reduce side effects
Cobbold SA, Vaughan AM, Lewis IA, Painter HJ, Camargo N, Perlman DH, Fishbaugher M, Healer J, Cowman AF, Kappe SH, and Llins M
It is designed as a triple receptor agonist , interacting with GLP-1, GIP, and glucagon receptors, making it a compound of significant interest in metabolic and endocrinology research
We've also got: - Everything that changed in NICE guidance in 2025-2026 - An HRT evidence review across 30+ publications from the last year - Rare disease in primary care - why awareness campaigns might not be enough Missed today's edition